“We commend the proposal by NASDAQ to require its more than 3,300 listed companies to include women, racial minorities, and LGBTQ individuals on their Board of Directors. Big changes require bold action. What NASDAQ has done will compel thousands of companies to implement meaningful, impactful change to their leadership and put us on the path to a more equitable, diverse, and inclusive future. We’re proud that so many of our life sciences company members already meet or exceed the NASDAQ diversity standard. We look forward to continuing our work to help our member companies become more diverse and inclusive and look more like the patient populations we all seek to serve.”
– Robert K. Coughlin, President & CEO, MassBio